Immune Fitness Prediction

The overall objective of the study is to determine whether self-rated, perceived immune fitness (using questionnaire) is associated with biological assessment of immune fitness (immune signatures in the blood).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Healthy Adults

Age range

35 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Nestlé Clinical Research Unit

Lausanne, Canton of Vaud, 1000, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ability to understand and sign the informed consent
Healthy adult men and/or women, 35-65 years old
BMI >18 and <30 kg/m2

Exclusion criteria

Volunteer who cannot be expected to comply with the protocol
Individuals with self-reported chronic disease; or who have any clinical condition which the investigator deems relevant for exclusion from the study,
Individuals with an impaired immune system that may confound immune response testing; i.e. any condition that impairs participant immune response through either the condition itself or through the treatment of the condition,
Family or hierarchical relationships with Clinical Innovation Lab at Nestlé Research, Lausanne, Switzerland

Treatment and study plan

Primary outcomes

Percentage of different immune cell types in whole blood

Time frame: 6 - 12 months after the start of the trial

Immune cell type profiling in whole blood by mass cytometry
Relative quantification of immune protein in plasma

Time frame: 6 - 12 months after the start of the trial

Proteomic analysis in plasma by proximity extension assay
Amount of cytokines expressed by peripheral blood mononuclear cells

Time frame: 6 - 12 months after the start of the trial

Cytokine quantification by proximity extension assay
Amount of analytes in serum

Time frame: 6 - 12 months after the start of the trial

Blood chemistry

Sponsors and collaborators

Lead sponsor

Société des Produits Nestlé (SPN)

Industry

Registry information

Official study title

Observational Study to Determine the Association Between Self-rated, Perceived Immune Fitness (Using Questionnaire) With Biological Assessment of Immune Fitness (Immune Signatures in the Blood).

Important dates

Study start: 2021
Primary completion: 2022
Study completion: 2022
First posted: Oct 14, 2021
Registry last updated: Feb 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed